Vedolizumab for induction and maintenance of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, July 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

blogs: 1 blog

twitter: 18 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 43 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 19 X posts from 18 X users, with an upper bound of 115,022 followers.

New NNT→Vedolizumab for induction and maintenance of remission in Crohn's disease https://t.co/1EmJZ1h7M7

Reply Repost Favourite

💊 #Vedolizumab for induction & maintenance of remission in #CrohnsDisease 📚 🔍 This @CochraneGut systematic review looks at the evidence from 4 studies including 1126 participants. 🌟 High‐certainty evidence that vedolizumab is effective https://t.co/d

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

Excellent 👌 and very comprehensive

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

Thanks to #rayboyapati for inviting me along for this. @ANZIBDC

Reply Repost Favourite

RT @BettenworthDb: Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomoll…

Reply Repost Favourite

Vedolizumab for induction and maintenance of remission in Crohn's disease. @IBD_JohnD https://t.co/1P3CqOwc58 @fgomollon @Y_ECCO_IBD @IBD_FloMD @GianlucaPellino @NuhaZsurgeon @DignassAxel @IBD_MB @RPanaccione @Iris_Dotan @EdwardLoftus2 @ibddoctor @pakotz

Reply Repost Favourite

Vedolizumab for induction and maintenance of remission in Crohn's disease https://t.co/X3Rhfii0p3

Reply Repost Favourite

Just Published 💊 #Vedolizumab for induction & maintenance of remission in #CrohnsDisease 📚 🔍 This @CochraneGut systematic review looks at the evidence from 4 studies including 1126 participants. 🌟 High‐certainty evidence that vedolizumab is effective

Reply Repost Favourite